Company Overview - Vir Biotechnology, Inc. (VIR) shares increased by 11.9% to close at $5.93, with trading volume significantly higher than usual, contrasting with a 2.2% loss over the past four weeks [1][2] Pipeline and Development - The rise in stock price is linked to positive investor sentiment regarding tobevibart, Vir Biotechnology's late-stage pipeline candidate, which is in a phase III ECLIPSE 1 study for chronic hepatitis delta (CHD) treatment [2] - The company is preparing to start a phase III ECLIPSE 2 study to evaluate the efficacy and safety of switching to tobevibart and elebsiran for CHD patients not achieving viral suppression with bulevirtide [2] Financial Expectations - The upcoming quarterly report is expected to show a loss of $0.74 per share, reflecting a year-over-year increase of 27.5%, while revenues are projected at $7.05 million, up 128.8% from the previous year [3] - The consensus EPS estimate for the quarter has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4] Industry Context - Vir Biotechnology operates within the Zacks Medical - Biomedical and Genetics industry, which includes other companies like Opus Genetics, Inc. (IRD), that also has a Zacks Rank of 2 (Buy) [4][5]

Company Overview - MiMedx (MDXG) shares increased by 8% in the last trading session, closing at $7, with higher trading volume compared to normal sessions [1] - The stock has shown a 0.5% gain over the past four weeks [1] - The rise in stock price is linked to investor optimism regarding the company's product portfolio in wound care, burn, and surgical sectors [1] Financial Performance - MiMedx is expected to report quarterly earnings of $0.06 per share, reflecting a year-over-year decline of 25% [2] - Revenue projections for the upcoming quarter are $89.28 million, which is a 2.4% increase from the same quarter last year [2] Earnings Estimates and Stock Movement - The consensus EPS estimate for MiMedx has remained unchanged over the last 30 days, indicating stability in earnings expectations [4] - Historical data suggests that stock prices typically do not continue to rise without trends in earnings estimate revisions [3][4] Industry Context - MiMedx operates within the Zacks Medical - Biomedical and Genetics industry, which includes other companies like PTC Therapeutics (PTCT) [5] - PTC Therapeutics has experienced a 0.7% decline in its stock price, with a return of -7.2% over the past month [5] - The consensus EPS estimate for PTC Therapeutics has decreased by 0.4% to -$1.07, representing a 7.8% increase from the previous year [6]

You're a self-proclaimed Democratic socialist running for mayor of the financial capital of the woods. New Yorkers are hungry for a different kind of politics. A politics that puts working people first.There is a new poll showing Zoran Mami actually leading Andrew Cuomo in New York City's race for mayor. This one poll hints at the possibility of a major political upset. My contrarian belief is that we'll see a rise, a dramatic rise in socialist movements in 2025 in the United States.Okay. And I think that s ...

Company Overview - Granite Ridge Resources, Inc. (GRNT) shares increased by 6.7% to close at $6.41, supported by higher trading volume compared to normal sessions [1] - The company is positioned to benefit from rising oil prices due to geopolitical tensions, particularly the conflict between Israel and Iran, which has led to a 13% increase in Brent crude and a 10% increase in West Texas Intermediate (WTI) [2] Financial Performance - Granite Ridge is expected to report quarterly earnings of $0.17 per share, reflecting a year-over-year increase of 30.8%, with revenues projected at $111 million, up 22.5% from the previous year [3] - The consensus EPS estimate for Granite Ridge has remained unchanged over the last 30 days, indicating stability in earnings expectations [4] Market Position - The company operates as a non-operated oil and natural gas exploration and production entity with a diverse portfolio across major U.S. basins, which enhances its operational flexibility and attractiveness in a volatile market [2] - Granite Ridge holds a Zacks Rank of 3 (Hold), indicating a neutral outlook in the current market context [5]

Core Viewpoint - Guidewire Software (GWRE) is expected to report significant growth in earnings and revenues for the upcoming quarter, with analysts projecting earnings of $0.46 per share and revenues of $285.72 million, reflecting year-over-year increases of 76.9% and 18.7% respectively [1] Earnings Projections - Analysts predict quarterly earnings of $0.46 per share, marking a 76.9% increase from the same period last year [1] - The consensus EPS estimate has remained unchanged over the past 30 days, indicating stability in analysts' projections [1] Revenue Estimates - Total revenues are forecasted to be $285.72 million, representing an 18.7% year-over-year increase [1] - 'Revenue- Subscription and support' is expected to reach $178.14 million, a 29.1% increase from the prior year [4] - 'Subscription Revenue' is projected at $162.74 million, indicating a 35.1% increase from the previous year [4] - 'Revenues- License' is estimated to be $55.33 million, reflecting a slight decrease of 1.6% from the prior year [4] Service and Support Revenue - 'Revenues- Services' is projected to be $52.00 million, showing an 11.8% year-over-year increase [5] - 'Support Revenue' is expected to decline to $15.41 million, a decrease of 12.2% from the previous year [5] - 'Term License Revenue' is estimated at $54.48 million, indicating a 1% decrease year-over-year [5] Annual Recurring Revenue - The consensus estimate for 'Annual recurring revenue' stands at $944.40 million, up from $828 million a year ago [6] Gross Profit Estimates - 'Gross profit- Subscription and support' is expected to be $120.51 million, compared to $86.79 million reported in the same quarter last year [6] - 'Gross profit- License' is projected to reach $54.87 million, slightly down from $55.37 million reported in the same quarter last year [7] Stock Performance - Guidewire Software shares have increased by 1.9% over the past month, while the Zacks S&P 500 composite has risen by 6.7% [7] - The company holds a Zacks Rank 3 (Hold), suggesting it is expected to closely follow overall market performance in the near term [7]

Core Insights - Wall Street analysts forecast Synopsys (SNPS) to report quarterly earnings of $3.39 per share, reflecting a year-over-year increase of 13% [1] - Anticipated revenues for Synopsys are projected to be $1.6 billion, indicating a 10.1% increase compared to the same quarter last year [1] - The consensus EPS estimate has remained unchanged over the past 30 days, suggesting a reassessment of projections by covering analysts [1] Revenue Estimates - Revenue from Maintenance and Service is expected to reach $279.24 million, showing a year-over-year change of +1% [3] - Total Products Revenue is estimated at $1.32 billion, indicating a +12.3% change from the prior-year quarter [4] - Revenue by segment for Design IP is projected to be $443.37 million, reflecting a +10.9% change from the year-ago quarter [4] - Revenue by segment for Design Automation is anticipated to reach $1.16 billion, indicating a +9.9% change from the prior-year quarter [4] - Upfront Products revenue is forecasted at $415.15 million, suggesting a +4.7% year-over-year change [5] - Time-based Products revenue is expected to come in at $904.12 million, reflecting a +15.7% change from the year-ago quarter [5] Stock Performance - Synopsys shares have increased by +14.7% in the past month, outperforming the Zacks S&P 500 composite, which has moved up by +10.7% [6] - The company holds a Zacks Rank 3 (Hold), indicating it is expected to closely follow overall market performance in the near term [6]

Core Insights - Analysts forecast Salesforce.com (CRM) to report quarterly earnings of $2.54 per share, reflecting a year-over-year increase of 4.1% [1] - Expected revenues are projected at $9.74 billion, indicating a 6.6% increase compared to the same quarter last year [1] - The consensus EPS estimate has remained unchanged over the past 30 days, suggesting analysts have reassessed their initial projections [1] Revenue Projections - Revenue from Professional services and other is estimated at $515.31 million, a decrease of 6% from the previous year [4] - Subscription and support revenue is projected to be $9.22 billion, showing an increase of 7.4% year-over-year [4] - Subscription and support - Service revenue is expected to reach $2.35 billion, reflecting a 7.6% increase from the prior year [5] - Subscription and support - Marketing and Commerce revenue is estimated at $1.35 billion, indicating a 5.2% year-over-year increase [5] - Subscription and support - Platform and Other revenue is projected at $1.83 billion, with a year-over-year change of 6.6% [6] - Subscription and support - Sales revenue is forecasted to be $2.14 billion, representing a 7.1% increase from the previous year [6] Geographic Revenue Estimates - Geographic Revenue from the Americas is expected to reach $6.63 billion, indicating a 9.4% increase year-over-year [6] - Geographic Revenue from Asia Pacific is projected at $982.26 million, reflecting a 6.1% increase [7] - Geographic Revenue from Europe is estimated to be $2.11 billion, showing a decrease of 1.4% from the previous year [7] Remaining Performance Obligation (RPO) - Current Remaining Performance Obligation (RPO) is projected to be $29.00 billion, up from $26.4 billion year-over-year [7] - Total Remaining Performance Obligation (RPO) is expected to reach $60.43 billion, compared to $53.9 billion in the same quarter last year [8] - Noncurrent Remaining Performance Obligation (RPO) is estimated at $31.44 billion, up from $27.5 billion year-over-year [8] Stock Performance - Salesforce.com shares have returned +7.1% over the past month, compared to a +10.7% change in the Zacks S&P 500 composite [8]

Analysts on Wall Street project that Booz Allen Hamilton (BAH) will announce quarterly earnings of $1.59 per share in its forthcoming report, representing an increase of 19.4% year over year. Revenues are projected to reach $3.02 billion, increasing 8.9% from the same quarter last year.The current level reflects an upward revision of 0.5% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial proj ...

Core Viewpoint - Analysts forecast that Bally's (BALY) will report a quarterly loss of $0.90 per share, reflecting a year-over-year increase of 72.4%, with anticipated revenues of $612.57 million, a decline of 1% compared to the previous year [1] Financial Projections - The consensus estimate for 'Revenue- Casinos & Resorts' is projected to reach $354.10 million, indicating a year-over-year increase of 3.4% [4] - 'Revenue- International Interactive' is expected to be $209.75 million, showing a decline of 10.6% from the prior-year quarter [4] - 'Revenue- North America Interactive' is estimated at $53.90 million, suggesting a year-over-year increase of 30% [4] Adjusted EBITDAR Estimates - Analysts estimate 'Adjusted EBITDAR- International Interactive' to be $80.25 million, down from $83.53 million in the same quarter last year [5] - The estimate for 'Adjusted EBITDAR- Casinos & Resorts' is $87.80 million, compared to $89.42 million in the previous year [5] Market Performance - Over the past month, Bally's shares have declined by 17%, while the Zacks S&P 500 composite has increased by 13.7% [5] - Bally's holds a Zacks Rank 1 (Strong Buy), indicating a potential for outperformance in the upcoming period [5]

Core Viewpoint - Sea Limited is expected to report significant year-over-year growth in earnings and revenues, with analysts projecting earnings of $0.93 per share and revenues of $4.91 billion for the upcoming quarter, reflecting increases of 342.9% and 29.7% respectively [1] Earnings Projections - The consensus EPS estimate has been revised downward by 1% in the past 30 days, indicating a reassessment by analysts [2] - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3] Revenue Estimates - Analysts estimate 'Revenue- E-Commerce' to be $3.63 billion, representing a year-over-year increase of 32% [5] - The consensus for 'Revenue- Digital Financial Services' is projected at $733.24 million, indicating a growth of 46.8% from the previous year [5] - 'Revenue- Other Services' is expected to reach $36.04 million, reflecting a year-over-year increase of 23.9% [5] User Metrics - Analysts project 'Quarterly paying users' to reach 53, up from 49 a year ago [6] - 'Quarterly active users' are expected to total 657, compared to 595 in the previous year [6] EBITDA Estimates - 'Adjusted EBITDA- Digital Entertainment' is projected at $322.55 million, an increase from $292.21 million reported in the same quarter last year [6] - 'Adjusted EBITDA- Digital Financial Services' is expected to be $225.87 million, up from $148.66 million a year ago [7] Stock Performance - Sea Limited's shares have returned +19.7% over the past month, outperforming the Zacks S&P 500 composite's +11.3% change [7]